Overview

Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics

Status:
Active, not recruiting
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of Harvoni in treatment-naïve alcoholic subjects with Genotype 1 HCV infection
Phase:
Phase 4
Details
Lead Sponsor:
University of Nebraska
Treatments:
Ledipasvir
Ledipasvir, sofosbuvir drug combination
Sofosbuvir